Ascendis Announces Planned $400 Million Share Repurchase Program

manilatimes.net · 2026-09-14

COPENHAGEN, Denmark, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that its Board of Directors has authorized the Company to repurchase up to $400 million of the Company’s ordinary shares (the Share Repurchase Program).

TickrTrends take: Ascendis Pharma announced a 400 million dollar share repurchase program, which represents a capital allocation decision that investors tracking the company's valuation should monitor for its impact on share count and earnings per share metrics. With TickrTrends currently awaiting full valuation on the Healthcare company, the repurchase program's execution timeline and funding source will be relevant factors as the valuation assessment develops. Shareholders should observe how this capital return commitment affects the company's financial flexibility and future cash flow projections in the context of its operational performance.

Read the full story at manilatimes.net →